U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C49H68N18O9S2.3C2H4O2
Molecular Weight 1297.465
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SETMELANOTIDE ACETATE

SMILES

CC(O)=O.CC(O)=O.CC(O)=O.C[C@H]1NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC4=CC=CC=C4)NC(=O)[C@H](CC5=CN=CN5)NC1=O)C(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O

InChI

InChIKey=PILXXDANZBQUJH-AKVBKPKISA-N
InChI=1S/C49H68N18O9S2.3C2H4O2/c1-26-41(70)63-37(20-30-22-55-25-59-30)46(75)64-35(18-28-10-4-3-5-11-28)44(73)62-34(15-9-17-57-49(53)54)43(72)65-36(19-29-21-58-32-13-7-6-12-31(29)32)45(74)66-38(40(50)69)23-77-78-24-39(47(76)60-26)67-42(71)33(61-27(2)68)14-8-16-56-48(51)52;3*1-2(3)4/h3-7,10-13,21-22,25-26,33-39,58H,8-9,14-20,23-24H2,1-2H3,(H2,50,69)(H,55,59)(H,60,76)(H,61,68)(H,62,73)(H,63,70)(H,64,75)(H,65,72)(H,66,74)(H,67,71)(H4,51,52,56)(H4,53,54,57);3*1H3,(H,3,4)/t26-,33+,34+,35-,36+,37+,38+,39+;;;/m1.../s1

HIDE SMILES / InChI
Setmelanotide (RM-493), is an investigational, first-in-class melanocortin-4 receptor (MC4R) agonist in development for the treatment of rare genetic disorders of obesity. Setmelanotide is thought to activate the MC4R, part of a key biological pathway in humans that regulates weight by increasing energy expenditure and reducing appetite. Variants in genes within the MC4 pathway are associated with unrelenting hunger, known as hyperphagia, and severe, early-onset obesity. Setmelanotide is a potential replacement therapy that may restore lost activity in the MC4 pathway, reestablishing weight and appetite control in patients with these rare genetic disorders.

Approval Year

PubMed

PubMed

TitleDatePubMed
Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.
2019 Mar 20

Sample Use Guides

Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) patients with moderate to severe obesity: Subcutaneous injection, 3 mg, daily
Route of Administration: Other
Setmelanotide (RM-493) binds human MC4R with Ki value of 0.71 nM in radioligand binding assay and activated MC4R with EC50 value of 1.5 nM in intracellular cAMP production assay.
Name Type Language
SETMELANOTIDE ACETATE
USAN  
Common Name English
SETMELANOTIDE ACETATE [ORANGE BOOK]
Common Name English
Setmelanotide acetate [WHO-DD]
Common Name English
IMCIVREE
Brand Name English
RM-493 ACETATE
Code English
Code System Code Type Description
FDA UNII
224I1W20I7
Created by admin on Sat Dec 16 16:05:16 GMT 2023 , Edited by admin on Sat Dec 16 16:05:16 GMT 2023
PRIMARY
CAS
1504602-49-6
Created by admin on Sat Dec 16 16:05:16 GMT 2023 , Edited by admin on Sat Dec 16 16:05:16 GMT 2023
NON-SPECIFIC STOICHIOMETRY
RXCUI
2469248
Created by admin on Sat Dec 16 16:05:16 GMT 2023 , Edited by admin on Sat Dec 16 16:05:16 GMT 2023
PRIMARY
PUBCHEM
155491122
Created by admin on Sat Dec 16 16:05:16 GMT 2023 , Edited by admin on Sat Dec 16 16:05:16 GMT 2023
PRIMARY PUBCHEM